16 Nov 2023 argenx announces European Commission approval of subcutaneous VYVGART® (efgartigimod alfa) for generalized myasthenia gravis Member news
15 Nov 2023 Orionis Biosciences announces first patient dosed in Phase 1 clinical trial of ORB-011 in patients with advanced solid tumors Member news
14 Nov 2023 SwiftPharma and PlantForm target blockbuster cancer drug with new contract manufacturing agreement for plant-made biosimilars Member news
13 Nov 2023 Biotech in Flanders - A Stunning Story: A new book reveals the secrets behind the success of the Flemish life sciences biotech industry Multiple categories
10 Nov 2023 miDiagnostics announces collaboration with Galapagos to develop closed-flow, ultra-rapid CAR-T sterility test for its point-of-care CAR-T manufacturing platform Member news
31 Oct 2023 Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business to Alfasigma Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
